For over thirty years, researchers have primarily studied the accumulation of amyloid beta proteins in the brains of Alzheimer’s patients. They also focus on how that component negatively impacts ...
Each monthly installment examines an aspect of Alzheimer's disease care, including making and delivering the diagnosis; ...
While companies developing drugs to treat Alzheimer's disease have spent decades and many billions of dollars targeting ...
Researchers have discovered a natural brain cleansing mechanism that helps individual neurons remove toxic tau protein, a key factor in Alzheimer's disease. This was reported on March 3 in the journal ...
While the research does not point to a direct, causal link, it hints that activities like reading, writing and playing games ...
Advanced practice providers expand access by conducting initial consults, ordering diagnostic workups, explaining anti-amyloid risk–benefit tradeoffs, and coordinating multidisciplinary stakeholders ...
Two new clinical trials aimed at treating Alzheimer’s disease are starting up at Barrow Neurological Institute.
In a study published in Nature Communications, Mayo Clinic researchers have identified specific DNA-level changes in the brains of people with Alzheimer's disease (AD). Using advanced biological ...
Researchers have developed a diagnostic panel that identifies cognitive decline by analyzing how blood proteins fold. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results